Philips to Help Develop AI and Machine Learning Healthcare Industry, as Supporter of UK Government's Early Diagnostics Industrial Strategy Challenge Fund

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a leader in health technology, is pleased to be associated with the government's recently announced £4.7 billion Industrial Strategy Challenge Fund. Working with public bodies, industry colleagues, the Office of Life Sciences and the Department of Business, Energy and Industrial Strategy, Philips will contribute to the development of artificial intelligence (AI) based and digital diagnostic solutions at scale. The fund will look to develop a trail-blazing digital pathology programme using artificial intelligence, and explore a similar programme within radiology. Philips is currently involved in a pilot exploring the use of networked digital pathology laboratories in Scotland, which could become a national model.

"Philips is proud to support this programme," comments Philips Electronics UK&I CEO Neil Mesher. "We're excited to be contributing to the possible development of a new global industry that utilises AI and machine learning. Philips believes that health knows no bounds and a campaign like this, which explores possibilities of accelerating diagnosis and improving accuracy, could have profound implications in disease areas such as cancer where precision diagnosis can be critical to patient survival."

Philips is a leader in computational and digital pathology, and is currently working with three NHS sites in Scotland to explore the use of networked digital pathology services to improve patient outcomes across urban, rural, and remote areas. If successful, the model could be rolled out nationally. In Northern Ireland Philips’ recent acquisition of PathXL, a digital pathology software company, has seen the workforce double within 12 months resulting in growth in the local economy and creation of a globally recognised digital pathology R&D hub in Belfast.

"Pathology is involved in 70% of the diagnoses made within the NHSi," comments Professor Manuel Salto-Tellez Clinical Professor, Director of the Precision Medicine Centre of Excellence in Queen's University Belfast. "In the UK, hospital treatments for over 75s have increased by 65% in the past decadei, growing the demand for pathology services. At Queen's we carry out leading digital pathology research to help meet this growing need. We believe digitised pathology can help to efficiently improve patient care by reducing human errors associated with sample handling, minimising variations in the clinical interpretation of data, and offering tools for increasingly sophisticated sample analysis."

In radiology Philips is a leading imaging equipment and service provider across the globe, with informatics solutions that securely co-ordinate and transfer patient data and images across healthcare delivery sites, providing fast access to standardised clinical images in support of improved diagnostic decision making.

The Early Diagnostics Industrial Strategy Challenge Fund programme will support healthcare providers, researchers and imaging companies to develop and evaluate new solutions that can reduce healthcare costs, improve clinical accuracy and improve patient outcomes and experiences. A recent survey carried out by Philips Healthcare found that 56%ii of the general population in the UK who had a cancer related experience felt 'connected care' technology made their experience more positive.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000 employees with sales and services in more than 100 countries.

Most Popular Now

Open Call SC1-DTH-01-2019: Big Data and …

Currently available methods and strategies for diagnosis and treatment of cancer help clinicians continuously improve quality of care and prevent cancer deaths in the population. Accurate risk assessment, availability of...

Cerner Selected for NHS Framework to Sup…

Integrated Care Systems (ICS) and Sustainability and Transformation Partnerships (STPs) aim to deliver the best possible quality of health and care, shift to value-based care and proactively improve outcomes for...

Brainlab and Magic Leap Partner in Digit…

Brainlab has announced a strategic development partnership with Florida-based Magic Leap, a developer of proprietary spatial computing solutions that help users enrich their real world experience by integrating digital content...

The Merck Accelerator Program 2019

The Merck Accelerator is looking for real partners so that you can work together in shaping the future. With programs in the headquarters in Germany, in China and the Satellites...

Whole-Brain Connectome Maps Teach Artifi…

Medical University of South Carolina (MUSC) neurologists have developed a new method based on artificial intelligence that may eventually help both patients and doctors weigh the pros and cons of...

Oxehealth Secures World-First Accreditat…

The British Standards Institute (BSI) has accredited Oxehealth's vital signs measurement software as a Class IIa medical device in Europe. This is the first time that software enabling a digital...

MEDICA 2018: The Starting Block for Many…

12 - 15 November 2018, Düsseldorf, Germany. MEDICA, the world’s leading medical trade fair in Düsseldorf which attracts over 5,000 exhibitors from around 70 countries, is becoming an even bigger hotspot...

MEDICA 2018 Presents the Future of Medic…

12 - 15 November 2018, Düsseldorf, Germany. Artificial intelligence, Big Data or IoT (Internet of Things) - we would be hard pressed to find a sector that doesn’t have these terms...

Artificial Intelligence for Health: ITU …

The ITU Focus Group on 'AI for Health' (FG-AI4H), created in collaboration with the World Health Organization (WHO), has issued a Call for Proposals to identify compelling use cases of...

Siemens Healthineers and STORZ MEDICAL P…

On the occasion of the 70th annual congress of the German Society for Urology, DGU, Siemens Healthineers and STORZ MEDICAL have announced plans to enter into a sales partnership agreement...

Spinal Cord Stimulation, Physical Therap…

Spinal cord stimulation and physical therapy have helped a man paralyzed since 2013 regain his ability to stand and walk with assistance. The results, achieved in a research collaboration between...

Sandoz Healthcare Access Challenge #Sand…

Sandoz, the Novartis generics and biosimilars division, today announces the launch of the second Sandoz Healthcare Access Challenge (HACk). The #SandozHACk is a global competition that invites entrepreneurs and innovators...